The expanded clearance allows patients with moderate to severe obstructive sleep apnea using the latest Inspire implants to undergo high-resolution 3.0 Tesla MRI scans under specified conditions.
A sleep physician shares a case report of how a patient with severe sleep apnea achieved objective and subjective improvements more quickly with Inspire Therapy than via the standard activation and titration protocols.
Inspire Medical executives speak about the number of patients impacted by the recall, the next steps, how the defect was identified, and the notification process.
Online support groups emerge as crucial resources for sleep apnea patients using neurostimulator treatments.
Read More
The approval provides reimbursement consistent with other European and global markets.
Read More
The new approval allows Inspire patients to undergo full-body MRI scans, expanding the previously limited scan areas and applying retroactively to all Inspire IV neurostimulator devices.
Read More
Inspire Medical’s sleep apnea treatment has received CE mark certification under the EU’s updated and more stringent Medical Device Regulation.
Read More
An otolaryngologist with Eastern Carolina ENT reached a milestone in offering surgical alternatives for obstructive sleep apnea.
Read More
The otolaryngology sleep team recently completed its 100th Inspire implant for obstructive sleep apnea patients.
Read More
Nick Lopez, 20, found relief from OSA after receiving Inspire therapy, now FDA-approved for Down syndrome patients as young as 13. Other neurostimulators are in the pipeline.
Read More
Inspire reported a 28% year-over-year revenue growth in Q1, driven in part by increased awareness of its Inspire therapy for sleep apnea.
Read More
For every unit of BMI increase over 32, the odds of successful treatment decrease by about 17%, a new study finds.
Read More
For drug-induced sleep endoscopy to determine sleep apnea therapy candidacy, the first 10+ minutes may not be representative of airway collapse.
Read More
Inspire Medical Systems reached a new milestone in the third quarter, surpassing 50,000 patients treated with Inspire therapy for obstructive sleep apnea.
Read More
A Florida hospital says it completed the state’s first Inspire implant surgery on a pediatric patient diagnosed with Down syndrome and sleep apnea.
Read More
The Tennessee-based team will present two research papers detailing the benefits of the Inspire neurostimulator and strategies to enhance CPAP compliance for sleep apnea patients.
Read More
The newly appointed chief medical officer will serve full-time on Inspire’s executive leadership team and lead the company’s medical and clinical affairs functions.
Read More
The reimbursement approval provides a pathway to open additional Inspire implanting centers in Belgium, while expanding access to care, according to Inspire Medical Systems.
Read More